TapewireFind a company

person · Reporting owner

Fernandez Calero Miguel Angel

Disclosed activity across 3 companies

Tapewire entity
114579
SEC CIK
0001472194

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AVON PRODUCTS INCAVP · Entity 152510Global PresidentJanuary 03, 2020January 07, 2020
HERBALIFE LTD.HLF · Entity 4842EVP, The Americas & WWD OpsMay 12, 2017May 15, 2017
TUPPERWARE BRANDS CORPTUP · Entity 90566Director · Chief Executive OfficerApril 06, 2023April 10, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AVON PRODUCTS INC

Report date January 03, 2020 · Filed January 07, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2020-01-03 transaction · row 1
1 source row

Row 1 · 2020-01-03 · Other · Disposed 100,000 · Balance 0

F1: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

Restricted StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2020-01-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-01-03 · Other · Disposed 683,407 · Balance 0

F1: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

Stock Option (Right to Buy)SEC Table II · derivative / convertible securityDirect0 Reported balance After 2020-01-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2020-01-03 · Other · Disposed 915,589 · Balance 0

F2: Each award of Avon Stock Options outstanding at the effective time of the Merger was canceled in exchange for the right to receive an amount in cash equal to the aggregate spread value of such award. 307,753 options had an exercise price of $3.44, 307,753 options had an exercise price of $3.49 and 300,083 options had an exercise price of $3.30. The closing price on the date of the Merger was $5.60.

Filing footnotes · ownership attribution and instrument terms

F1: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

F2: Each award of Avon Stock Options outstanding at the effective time of the Merger was canceled in exchange for the right to receive an amount in cash equal to the aggregate spread value of such award. 307,753 options had an exercise price of $3.44, 307,753 options had an exercise price of $3.49 and 300,083 options had an exercise price of $3.30. The closing price on the date of the Merger was $5.60.

HERBALIFE LTD.

Report date May 12, 2017 · Filed May 15, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2017-05-12 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2017-05-12 · Sale · Disposed 30,401 · Balance 0

F1: This transaction was executed in multiple trades at prices ranging from $71.71 to $72.28. The price reported above reflects the weighted average purchase price of $72.02. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The total number of shares has been adjusted to reduce the share balance by 25 shares inadvertently included in prior reports.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $71.71 to $72.28. The price reported above reflects the weighted average purchase price of $72.02. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The total number of shares has been adjusted to reduce the share balance by 25 shares inadvertently included in prior reports.

TUPPERWARE BRANDS CORP

Report date April 06, 2023 · Filed April 10, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect595,740 Ending reported balance After 2023-04-06 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2023-04-06 · Tax withholding · Disposed 34,540 · Balance 444,440

F1: Shares were withheld by the Issuer upon the vesting of 1/3 of the reporting person's April 6, 2020 restricted stock units award to cover the resulting tax liability. On April 6, 2020, the reporting person was granted 425,532 restricted stock units with a vesting schedule of 3 equal annual installments beginning on April 6, 2021, the first anniversary of the grant.

Row 2 · 2023-04-06 · Grant · Acquired 151,300 · Balance 595,740

F2: Represents shares awarded to reporting person in connection with the vesting of performance-based PSUs initially awarded on April 6, 2020. 48,700 shares were surrendered to cover the resulting tax liability.

Filing footnotes · ownership attribution and instrument terms

F1: Shares were withheld by the Issuer upon the vesting of 1/3 of the reporting person's April 6, 2020 restricted stock units award to cover the resulting tax liability. On April 6, 2020, the reporting person was granted 425,532 restricted stock units with a vesting schedule of 3 equal annual installments beginning on April 6, 2021, the first anniversary of the grant.

F2: Represents shares awarded to reporting person in connection with the vesting of performance-based PSUs initially awarded on April 6, 2020. 48,700 shares were surrendered to cover the resulting tax liability.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 09, 2017 Filed May 12, 2017 00:35 UTC HERBALIFE LTD. HLF · Entity 4842 Tax withholdingCommon Stock 915 $72.81 $66,621.15
Disclosure

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 3

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,223

F1 · kind: The reporting person received 1,698 shares of common stock upon the net exercise of the 9,750 stock appreciation rights ("SARS"). The reporting person forfeited 7,137 shares of common stock underlying the SARS in payment of the exercise price and 915 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

Read SEC document
May 09, 2017 Filed May 12, 2017 00:35 UTC HERBALIFE LTD. HLF · Entity 4842 Disposition to issuerCommon Stock 7,137 $72.81 $519,644.97
Disclosure

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,138

F1 · kind: The reporting person received 1,698 shares of common stock upon the net exercise of the 9,750 stock appreciation rights ("SARS"). The reporting person forfeited 7,137 shares of common stock underlying the SARS in payment of the exercise price and 915 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

Read SEC document
May 09, 2017 Filed May 12, 2017 00:35 UTC HERBALIFE LTD. HLF · Entity 4842 Exercise / conversionCommon Stock 9,750 $53.29 $519,577.50
Disclosure

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2017 Filed Feb 28, 2017 00:16 UTC HERBALIFE LTD. HLF · Entity 4842 GrantStock Appreciation Rights · Derivative 4,367 $0.00 Strike: $62.51 $0.00
Disclosure

SEC source: 0001209191-17-014988 · doc4.xml · derivative · entry 3

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,367

Underlying: Common Stock · 4,367 shares

Expires 2026-05-09

F3 · balance_after: On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017.

Read SEC document
February 23, 2017 Filed Feb 28, 2017 00:16 UTC HERBALIFE LTD. HLF · Entity 4842 GrantStock Appreciation Rights · Derivative 10,603 $0.00 Strike: $30.44 $0.00
Disclosure

SEC source: 0001209191-17-014988 · doc4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,206

Underlying: Common Stock · 10,603 shares

Expires 2025-03-02

F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 53,017 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017.

Read SEC document
February 23, 2017 Filed Feb 28, 2017 00:16 UTC HERBALIFE LTD. HLF · Entity 4842 GrantStock Appreciation Rights · Derivative 15,011 $0.00 Strike: $59.98 $0.00
Disclosure

SEC source: 0001209191-17-014988 · doc4.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,019

Underlying: Common Stock · 15,011 shares

Expires 2024-04-30

F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 25,019 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 15,011 SARs which will vest on April 30, 2017.

Read SEC document
April 27, 2016 Filed Dec 30, 2016 21:08 UTC HERBALIFE LTD. HLF · Entity 4842 GrantStock Appreciation Rights · Derivative 9,079 $0.00 Strike: $79.58 $0.00
Disclosure

SEC source: 0001209191-16-157081 · doc4.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,133

Underlying: Common Stock · 9,079 shares

Expires 2023-12-19

F1 · derivative.exercise_date: On December 19, 2013, the reporting person was granted an award of 15,133 stock appreciation rights (SARs). The amount and timing of the vesting of these SARs were dependent upon Herbalife Ltd.'s achievement of certain performance criteria for each of fiscal 2013, 2014 and 2015. The performance criteria were met in 2015, resulting in the vesting of 9,079 SARs subject to this award on June 21, 2016.

F1 · balance_after: On December 19, 2013, the reporting person was granted an award of 15,133 stock appreciation rights (SARs). The amount and timing of the vesting of these SARs were dependent upon Herbalife Ltd.'s achievement of certain performance criteria for each of fiscal 2013, 2014 and 2015. The performance criteria were met in 2015, resulting in the vesting of 9,079 SARs subject to this award on June 21, 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.